SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-04-034734
Filing Date
2004-11-09
Accepted
2004-11-09 16:10:04
Documents
9
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a04-12613_110q.htm 10-Q 774272
2 EX-10.1 a04-12613_1ex10d1.htm EX-10.1 697617
3 EX-10.2 a04-12613_1ex10d2.htm EX-10.2 269063
4 EX-10.3 a04-12613_1ex10d3.htm EX-10.3 98214
5 EX-10.4 a04-12613_1ex10d4.htm EX-10.4 72553
6 EX-31.1 a04-12613_1ex31d1.htm EX-31.1 8784
7 EX-31.2 a04-12613_1ex31d2.htm EX-31.2 9674
8 EX-32.1 a04-12613_1ex32d1.htm EX-32.1 7118
9 GRAPHIC g126132kcimage002.gif GRAPHIC 2127
  Complete submission text file 0001104659-04-034734.txt   1941872
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
SUPERGEN INC (Filer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27628 | Film No.: 041129771
SIC: 2834 Pharmaceutical Preparations